FRIEDL-NADERER JOHANNA (Chief Commercial Officer) sold 0.1% of their position (226.00 shares) of DYNE THERAPEUTICS, INC. on the open market
Open‑market sale worth $5.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/17/2026ACC: 0001915598-26-000004
Officer· Chief Commercial Officer
Since Mar 2026
-226.00
Net shares
Net seller
$5.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
226.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−226.00
Price / share
$26.28
Trade value
$5.94K
% of position
0.1%
8/13/2026
154.21K→153.98K
Total
Net shares
−226.00
Net value
-$5.94K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/13/2026 | S · Sale | −226.00 | $26.28 | $5.94K | 0.1% | 154.21K | 153.98K |
| Total | −226.00 | -$5.94K | ||||||
Derivative Transactions0
No derivative transactions reported